Skip to main navigation Skip to search Skip to main content

A core outcome set for future male infertility research: development of an international consensus

  • Michael P. Rimmer*
  • , Ruth A. Howie
  • , Richard A. Anderson
  • , Christopher L. R. Barratt
  • , Kurt T. Barnhart
  • , Yusuf Beebeejaun
  • , Ricardo Pimenta Bertolla
  • , Pietro Bortoletto
  • , Robert E. Brannigan
  • , Astrid E. P. Cantineau
  • , Ettore Caroppo
  • , Barbara L. Collura
  • , Kevin Coward
  • , William Colin Duncan
  • , Michael L. Eisenberg
  • , Steven A. Gellatly
  • , Christian De Geyter
  • , Dimitrios G. Goulis
  • , Ralf R. Henkel
  • , Vu N. A. Ho
  • Alayman F. Hussein, Carin Huyser, Jozef H. Kadijk, Mohan S. Kamath, Shadi Khashaba, Hajra Khattak, Yoshitomo Kobori, Julia Kopeika, Tansu Kucuk, Saturnino Luján, Thabo Christopher Matsaseng, Raj S. Mathur, Kevin McEleny, Rod T. Mitchell, Ben W. Mol, Alfred M. Murage, Ernest H. Y. Ng, Allan Pacey, Antti H. Perheentupa, Stefan du Plessis, Nathalie Rives, Ippokratis Sarris, Peter N. Schlegel, Majid Shabbir, Maciej Śmiechowski, Venkatesh Subramanian, Sesh K. Sunkara, Basil C. Tarlarzis, Frank Tüttelmann, Andy Vail, Madelon van Wely, M. nica H. Vazquez-Levin, Lan N. Vuong, Alex Y. Wang, Rui Wang, James M. N. Duffy, Cindy M. Farquhar, Craig Niederberger
*Corresponding author for this work
  • University of Edinburgh
  • University of Dundee
  • University of Pennsylvania
  • King's College London
  • Universidade Federal de São Paulo
  • Wayne State University
  • Boston IVF
  • Northwestern University
  • University of Groningen
  • Asl Bari
  • RESOLVE: The National Infertility Association
  • University of Oxford
  • Stanford University
  • University of Basel
  • Aristotle University of Thessaloniki
  • Imperial College London
  • University of the Western Cape
  • LogixX Pharma
  • My Duc Hospital
  • Minia University
  • University of Pretoria
  • Freya Dutch Infertility Association
  • Christian Medical College
  • University of New South Wales
  • IVFAustralia
  • University College London
  • Dokkyo Medical University
  • Guy's and St Thomas' NHS Foundation Trust
  • Acibadem Maslak Hospital
  • Hospital Universitario La Fe
  • Stellenbosch University
  • Manchester University NHS Foundation Trust
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • Monash University
  • Harley Street Fertility Centre
  • The University of Hong Kong
  • University of Manchester
  • University of Turku
  • Mohammed Bin Rashid University of Medicine and Health Sciences
  • Université de Rouen Normandie
  • PLLC
  • Association for Infertility Treatment and Adoption Support “Our Stork”
  • Fertility Europe
  • University of Münster
  • Centre for Reproductive Medicine
  • Amsterdam UMC
  • Consejo Nacional de Investigaciones Científicas y Técnicas
  • University of Medicine and Pharmacy at Ho Chi Minh City
  • University of Technology Sydney
  • The University of Sydney
  • Barts Health NHS Trust
  • Cochrane Gynaecology and Fertility Group
  • The University of Auckland
  • University of Illinois at Chicago

Research output: Contribution to journalArticleAcademicpeer-review

27 Downloads (Pure)

Abstract

Objective: To develop a core outcome set for male infertility trials. Design: A two-round Delphi survey and consensus development workshop were undertaken with healthcare professionals, researchers and clinicians globally. Subjects: 334 participants from 39 countries participated in the Delphi Survey, while 44 participants from 21 countries participated in the consensus development workshop. Exposure: NA Main Outcome Measures: The core outcome set for male infertility trials has been developed by the inclusion of specific male-factor outcomes in addition to the general infertility core outcome set which focuses on female-factor outcomes. Results: The outcomes identified include assessment of semen using the World Health Organisation recommendations for semen analysis; viable intrauterine pregnancy confirmed by ultrasound (accounting for singleton, twin and higher multiple pregnancies); pregnancy loss (accounting for ectopic pregnancy, miscarriage, stillbirth and termination of pregnancy); live birth; gestational age at delivery; birthweight; neonatal mortality; and major congenital anomaly. Although not a requirement as part of the core outcome set, other outcomes were identified as potentially useful in certain study settings. Conclusion: Embedding the core outcome set within RCTs and systematic reviews should ensure the comprehensive selection, collection and reporting of core outcomes, which are inconsistently reported at present. Research funding bodies, the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement, and over 80 specialty journals, including the Cochrane Gynaecology and Fertility Group, Fertility and Sterility and Human Reproduction, have committed to implementing this core outcome set for male infertility trials. Trial Registration Number: Core Outcome Measures in Effectiveness Trials (COMET) initiative registration No: 1586. Available at www.comet-initiative.org/Studies/Details/1586.

Original languageEnglish
Pages (from-to)1017-1028
Number of pages12
JournalHuman reproduction (Oxford, England)
Volume123
Issue number6
Early online date2025
DOIs
Publication statusPublished - Jun 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Delphi survey
  • consensus development study
  • core outcome sets
  • male infertility
  • outcome measures
  • outcomes
  • randomized control trials

Fingerprint

Dive into the research topics of 'A core outcome set for future male infertility research: development of an international consensus'. Together they form a unique fingerprint.

Cite this